OmeCare: Investor Sues Genetics Co. In Del. After Mystery Merger
A lender and shareholder who invested more than $10 million in Pathway Genomics Corp. sued the California-based genetics testing company in Delaware's Chancery Court late Friday, demanding to know why it suddenly started operating as OmeCare without notice or explanation to investors.
Read full article »
CEO
Pathway Genomics provides physicians with genetic testing reports on diet, exercise, drug response, carrier status and health conditions.
Read more